THCa Hemp Bans: Cannabis Industry Influence and Scandals

Overview of THCA Hemp and Recent Bans

Tetrahydrocannabinolic acid (THCA) is the non-psychoactive precursor to THC found in raw cannabis. When heated (through smoking, vaping, or cooking), THCA decarboxylates into THC, producing the same intoxicating effect as marijuana . This fact created a “hemp loophole” after the 2018 Farm Bill – vendors could sell high-THCA hemp flower (with low Δ9-THC on paper) as “legal hemp,” even though consumers could simply heat it to obtain psychoactive THC. In essence, hemp-derived THCA flower is chemically the same product as regulated cannabis flower once used, blurring the line between “hemp” and “marijuana.” This overlap has led to a wave of state bans and regulatory crackdowns on THCA-rich hemp products, often amid allegations of corrupt influence by the licensed cannabis industry seeking to eliminate competition.

Over the past few years, many U.S. states have moved to ban or restrict THCA and other “intoxicating hemp” products (like Δ8-THC), citing public health concerns – but notably, these bans frequently occur in states that already have legal cannabis programs or launched them shortly after. Cannabis companies have a financial incentive to lobby for such bans: unregulated THCA hemp can undercut the legal marijuana market by offering essentially the same high without the taxes or strict licensing fees. Below, we explore the pattern of state THCA hemp bans correlating with legal cannabis, the role of industry lobbying (and even bribery), and a case study involving Trulieve – one of America’s largest cannabis firms – whose CEO’s husband was embroiled in a bribery scandal over cannabis licenses.

States Banning THCA While Embracing Legal Cannabis

By mid-2025, nearly half of U.S. states had effectively outlawed hemp-derived THCA and similar cannabinoids, typically by classifying them as illegal THC or by restricting sales to licensed cannabis stores . Tellingly, most of these states either have established medical or recreational cannabis markets or enacted bans as they were preparing to roll out such programs. In other words, the prohibition of THCA hemp often goes hand-in-hand with the interests of state-sanctioned cannabis operators. The following examples highlight this trend:

• Alaska (Recreational cannabis legal): Despite being an early recreational marijuana state, Alaska closed the hemp loophole by classifying all tetrahydrocannabinols and their isomers as Schedule IIIA controlled substances. This effectively bans any hemp-derived THC variant (Δ8, Δ10, THCA, etc.) outside the licensed marijuana program . In short, unregulated hemp “high” products are illegal even though Alaska’s state-legal cannabis is available.

• California (Recreational legal): California regulators in late 2024 adopted emergency rules barring the sale of any hemp product containing detectable THC or intoxicating cannabinoids (e.g. Δ8-THC, THCA, THC-O) outside of the state’s licensed cannabis dispensaries . Even CBD products cannot have more than 0.3% THC under these rules. This blanket ban forces consumers into the taxed dispensary system for any THC, a move welcomed by California’s $32 billion legal marijuana industry, since it “steers [consumers] squarely toward licensed cannabis stores” and cuts out unregulated competitors .

• Colorado (Recreational legal): Colorado – another pioneering legal-cannabis state – has likewise outlawed hemp-derived THC isomers outside the regulated market. The state’s law defines “tetrahydrocannabinols” to include any isomer or synthetic equivalent of THC, and in 2021 Colorado’s health department explicitly ruled that chemically converting hemp CBD to Δ8/Δ9-THC is not compliant with hemp law . In effect, products like Δ8-THC or THCA flower are treated as illegal unless sold through Colorado’s licensed marijuana system . (Notably, Colorado officials reported that the marijuana lobby had strongly pushed for a complete ban on intoxicating hemp products , underscoring industry influence in this policy.)

• Massachusetts (Recreational legal): After legalizing adult-use cannabis, Massachusetts moved in 2021 to prohibit hemp-derived THC products outside of dispensaries. State guidance banned the manufacture or sale of any Δ8-THC products from hemp, deeming them controlled substances unless distributed within the licensed cannabis market . No hemp THCA or Delta-8 gummies/vapes can be sold legally except by state-licensed marijuana retailers , effectively eliminating unlicensed competition.

• Nevada (Recreational legal): Nevada updated its controlled substances law in 2021 to include all THC isomers (Δ7, Δ8, Δ10, etc.) in the definition of THC and to ban any “synthetic cannabinoid” not directly from the plant . Thus, hemp-derived Δ8, Δ10, THCA and similar products are illegal in Nevada outside the regulated dispensary system – a protective measure for the state’s recreational cannabis industry.

• Oregon (Recreational legal): Oregon – with a robust legal cannabis market – enacted a 2022 law to eliminate unregulated hemp THC sales. It forbids selling any product containing “artificially derived cannabinoids” (like Δ8 synthesized from hemp CBD) outside the state’s marijuana dispensaries . The law also set strict potency limits (e.g. max 2 mg THC per serving) for general retail hemp products . In practice, hemp-derived THCA flower, Δ8 edibles, and similar intoxicants can only be sold through licensed cannabis stores in Oregon , making them virtually banned from regular retail.

• Rhode Island (Recreational legal since 2022; medical program): Rhode Island’s law considers all forms of THC to be “marijuana” under its controlled substances act unless part of the state-regulated medical or adult-use program. The definition of marijuana covers “every compound, derivative, or preparation” of the cannabis plant . This means hemp-derived THCA, Δ8, etc., are treated as Schedule I illegal drugs in Rhode Island – only licensed dispensaries in the medical or newly legal recreational market can distribute THC products .

• Delaware (Medical cannabis; recently legalized recreational in 2023): Delaware law broadly bans any product containing “any quantity of…tetrahydrocannabinols” that isn’t an FDA-approved drug . Δ8-THC, Δ10-THC, HHC, THCA and the like are all classified as Schedule I substances, making their sale or possession illegal . This strict ban was in place while Delaware had only medical marijuana; in 2023 the state legalized adult-use cannabis, but maintained the prohibition on hemp-derived THC products to ensure only the regulated market can offer intoxicants.

• Mississippi (Medical cannabis legal): Shortly after Mississippi launched a medical marijuana program in 2022, the state moved to outlaw all forms of THC from hemp. Mississippi’s law classifies all “isomers, derivatives, and synthetic substances” of THC as Schedule I drugs (aside from a few approved pharmaceuticals) . The state even set a strict 20:1 CBD-to-THC ratio and max 2.5 mg THC per mL for any cannabis extracts, effectively banning any meaningful amount of THC in “hemp” products . As a result, hemp THCA flower, Δ8 gummies, and similar products are illegal in Mississippi, protecting the nascent medical cannabis industry from unregulated rivals.

• Arkansas (Medical cannabis legal): In 2023, Arkansas enacted Act 629, adding Δ8-THC, Δ9-THC, and Δ10-THC derived from hemp to the state’s Schedule VI controlled substances (the same category as marijuana). This law prohibits the production, sale, or possession of any hemp product containing those THC isomers . Arkansas essentially treated hemp-derived THC identical to cannabis, banning THCA products while continuing to allow only licensed medical marijuana sales.

• South Dakota (Medical cannabis legal): South Dakota – which implemented a medical marijuana program in 2021 – passed legislation in 2024 to crack down on hemp-derived intoxicants. The law forbids the conversion of hemp CBD into THC isomers like Δ8-THC or THCA, classifying those processes and products as illegal . In practice, any hemp product intended to deliver a THC-like high is banned in South Dakota, unless obtained through the state’s regulated medical cannabis channels.

• Alabama (Medical program starting): Alabama approved medical cannabis in 2021 and began licensing dispensaries in 2023–2024. In May 2025, Gov. Kay Ivey signed a “hemp killer” bill that will outlaw smokable hemp products (including THCA flower) and heavily regulate consumable hemp beginning Jan. 2026 . The new Alabama law bans any hemp-derived product that can get you “high,” effectively forcing consumers to the forthcoming medical cannabis market for THC products. (Multiple raids on CBD shops occurred ahead of the ban’s implementation , showing the state’s intent to strictly enforce it.)

• Texas (Very limited medical program): Texas moved aggressively in 2025 to shut down its booming hemp cannabinoid market. The legislature passed Senate Bill 3 to prohibit manufacturing or selling any hemp product containing any amount of THC (or its isomers), except for non-intoxicating cannabinoids like CBD/CBG . “We are not banning hemp. We are banning high,” declared one Texas lawmaker in support of the bill . This would wipe out products like THCA flower and Δ8 edibles in Texas. Notably, at the same time, Texas lawmakers have debated expanding the state’s extremely limited THC medical program (which currently allows only low-THC oils) . In fact, the Texas House signaled reluctance to fully ban hemp-derived THC unless the medical cannabis program is broadened, highlighting the link between the two issues .

• Tennessee (No recreational or medical cannabis program): Even states without legal marijuana have targeted the hemp loophole. In 2023, Tennessee approved a law (effective Jan. 2026) banning products that contain THCA or synthetic cannabinoids, and even prohibiting online sales of other hemp products . Tennessee’s ban is notable because the state has no cannabis dispensary system to fall back on – reflecting a generally prohibitionist stance. (Similarly, ultra-conservative states like Idaho and Kansas, which outlaw marijuana entirely, also ban hemp-derived THC across the board as a matter of zero-tolerance policy.)

The pattern is clear: States that legalize and regulate cannabis often don’t tolerate unregulated competition from hemp-derived THC. They frequently tighten their laws to include THCA and other “loophole” cannabinoids in the definition of illegal marijuana, or explicitly restrict their sale to licensed cannabis businesses. Policymakers and industry advocates claim these steps are about consumer safety and closing legal gray areas, but they also conveniently protect the licensed cannabis companies’ market share. As one hemp/cannabis trade group president put it, these state-by-state “battles” pit the goal of preserving the “integrity of state-regulated [cannabis] markets” against the influx of unregulated, untaxed THC products . In other words, many legislators are responding to pressure to “preserve…state-regulated markets” by eliminating what legal cannabis operators see as an “unwelcome competitor” in intoxicating hemp products .

Cannabis Industry Lobbying and Influence on Hemp Bans

Behind many THCA hemp bans is active lobbying by cannabis businesses and their allies. Licensed marijuana operators argue that untested hemp-derived THC products pose health and safety risks and undermine the controlled system states set up. However, there is a strong profit motive as well: hemp THCA and Δ8 products often sell much cheaper than dispensary cannabis (no hefty taxes or seed-to-sale tracking costs), so they threaten the profitability of legal sellers.

In Colorado, for example, regulators noted that if they didn’t heavily regulate intoxicating hemp products, it likely would have led to “complete prohibition” of those items – “something the state’s marijuana lobby was strongly pushing for,”according to a legal analysis . The marijuana industry in Colorado wanted a full ban on hemp-derived competitors, and the state ended up enacting strict rules to appease those concerns. Similarly, in California, the crackdown on hemp THC was essentially celebrated by cannabis companies. Governor Gavin Newsom’s office touted 99% compliance with the hemp-THC ban as a win for the licensed industry – a “dream scenario” where consumers have no choice but to buy from state-licensed stores . Cannabis businesses in California had complained that cheap delta-8 vapes and hemp gummies undercut dispensary sales; with the 2024 ban in place, those unlicensed products have largely vanished, and legal retailers benefit from the reduced competition .

Even in states just launching cannabis programs, incumbent operators push to stamp out hemp rivals. In Ohio, which approved adult-use marijuana in 2023, operators in the newly emerging market view intoxicating hemp products as “unwelcome” competition and have supported legislation to rein them in . Indeed, Ohio lawmakers introduced a bill to limit sales of delta-8 and THCA items to only state-licensed cannabis stores . This would channel hemp-derived products into the same taxed dispensaries, ensuring established cannabis firms don’t lose customers to independent CBD shops selling “THC-lite” goods.

It’s not just state-level actors. National cannabis MSOs (multi-state operators) have also taken positions on the hemp loophole. Some large marijuana companies initially called for federal action to ban lab-made delta-8 THC, but sensing an opportunity, a few have pivoted to join the hemp-derived market themselves (hedging their bets in case the loophole remains) . For instance, Curaleaf (a major MSO) launched its own line of hemp THC products and opened a hemp store in Florida . This indicates that big cannabis is keenly aware of the hemp-derived THC segment – they either want it gone or want a piece of it. Trade organizations like the American Trade Association for Cannabis and Hemp have been lobbying Congress to address the issue uniformly, framing it as needed to protect consumers and legitimate companies from a “fragmented landscape” of unregulated intoxicants .

At the same time, hemp industry advocates accuse the marijuana lobby of trying to “kill” the hemp sector for profit. The U.S. Hemp Roundtable and similar groups argue that not all hemp-derived products are dangerous, and that blanket bans destroy small businesses and farmer livelihoods. In Texas, for example, hemp businesses mustered over 100,000 petition signatures urging the governor to veto the 2023–25 ban bills . While some states compromised by imposing age limits or potency caps instead of outright bans, the overall trend – driven by well-funded cannabis interests and alarmist rhetoric about “copycat edibles” attracting kids – has been toward strict prohibition of hemp THCs outside the licensed system.

Federal Moves to Close the “Hemp Loophole”

As more states crack down, the federal government is also weighing action. In June 2025, a U.S. House committee advanced a provision – tagged by critics as a “hemp-killing” measure – aimed at outlawing intoxicating hemp products nationwide . Rep. Andy Harris (R-Md.) inserted language into a must-pass FDA/agriculture appropriations bill that would redefine “hemp” in federal law to exclude products containing “quantifiable amounts” of THC or THCA . In plain terms, any hemp-derived product that can get users high (including high-THCA flower) would become illegal under federal statute, closing the loophole left by the 2018 Farm Bill. The proposal also bans synthetic cannabinoids outright .

During the committee debate, Rep. Harris argued that Congress needed to act because dozens of states have already stepped in to curb “these dangerous products” and protect children . He cited reports of unregulated delta-8 THC edibles sickening minors and said the hemp loophole has led to a flood of “intoxicating cannabinoid products” being sold openly . The measure, if enacted, would force hemp manufacturers to comply with a THC-free standard or go through the full FDA approval process for any intoxicating product – effectively wiping out the delta-8/THCA niche unless those products are regulated like marijuana.

Hemp industry representatives fiercely oppose Harris’s provision, warning it would bankrupt many farms and retailers. They note that the 2018 Farm Bill legalized hemp as an agricultural commodity and that banning derivatives post-hoc undermines the industry. But the political momentum against hemp-derived highs is strong. Even bipartisan bills (such as one by Sen. Ron Wyden) that sought a middle ground – regulating hemp products for safety and age-restrictions while banning synthetic conversions – have stalled amid calls for a stricter solution . As of mid-2025, Congress had yet to finalize the new Farm Bill, leaving states to continue patchwork enforcement in the interim . The direction seems clear: the federal government may soon mirror what many states have done, formally outlawing THCA and similar hemp products to “close the loophole.” If that happens, it will be a major win for licensed cannabis operators – effectively eliminating their low-cost competition at the national level.

Case Study: Trulieve CEO’s Husband Bribery Scandal

Allegations of corruption in cannabis policymaking are not just theoretical – a high-profile case in Florida revealed brazen bribery and influence-peddling tied to a leading cannabis company. Trulieve is one of the largest cannabis MSOs in the U.S. (commanding roughly 50% of Florida’s half-billion-dollar medical marijuana market ). In 2021, the husband of Trulieve’s CEO, Kim Rivers, was convicted on federal corruption charges for actions that included bribing public officials and manipulating state cannabis licensing rules to benefit himself and associates .

Kim Rivers’ husband, John “JT” Burnette, was a prominent businessman in Tallahassee who became embroiled in an FBI sting targeting city government corruption. In August 2021, a jury found Burnette guilty on five felony counts – including extortion, honest services fraud, and making false statements – stemming from a multi-year bribery scheme . He conspired with then-Tallahassee City Commissioner Scott Maddox (a former mayor) and Maddox’s business partner, Paige Carter-Smith, to sell influence at City Hall . According to prosecutors, Burnette leveraged his “power and wealth to corrupt the political process” . For example, in 2014 he paid Maddox a $100,000 bribe to get the city to quash a rival developer’s hotel project that would have competed with Burnette’s own hotel . Later, in 2016–2017, he acted as a middleman to funnel $40,000 in bribes from undercover FBI agents (posing as developers) to Maddox in exchange for favorable votes, not realizing those “developers” were part of an FBI operation .

Burnette was sentenced to three years in federal prison and fined $1.25 million for his role in the corruption scheme . (Prosecutors had originally sought a harsher 8-year term given the seriousness of the offenses .) But beyond the local bribery involving city projects, what’s striking is how this case intersected with state cannabis law. During the investigation, FBI recordings captured Burnette bragging about his influence over Florida’s marijuana licensing. He told undercover agents that he had convinced a state lawmaker – then-Rep. Halsey Beshears – to insert a “controversial barrier to entry” into Florida’s 2017 medical marijuana legislation that “would benefit both Burnette and the Beshears family,” according to federal prosecutors . Specifically, Burnette claimed credit for a rule requiring any medical cannabis license applicant to have operated as a plant nursery in Florida for 30 years . This infamous 30-year nursery requirement was indeed written into Florida’s law, and it drastically limited who could qualify for a cannabis license. The rule locked out many Black farmers and small startups (who by definition couldn’t meet a 30-year operating history) and ensured that only a handful of large, established nurseries could apply . Burnette – who had business ties in the industry – and Rep. Beshears (whose family owned a century-old nursery) stood to gain from this constraint on competition .

On the witness stand, Burnette later tried to downplay these boasts, claiming he only said what he thought the undercover agents “wanted to hear” and that they had egged him on to take credit for the 30-year rule . Regardless, his recorded statements reinforced a public perception that Florida’s early medical cannabis market was essentially “rigged” by insiders. The initial licensing round (in which Trulieve’s predecessor received a license) disproportionately favored a few well-connected nursery businesses – a fact that has drawn lawsuits and legislative scrutiny in Florida. Burnette’s case was a rare instance of someone being caught on tape essentially claiming to have written the rules to benefit himself and a political ally.

It’s important to note that Trulieve and CEO Kim Rivers were not charged with any wrongdoing in Burnette’s case. The company asserted that neither Trulieve nor Rivers were involved or aware of Burnette’s illicit activities . In fact, Rivers kept her position as CEO throughout the trial, and Trulieve’s board issued a statement of “strong support” for her leadership after Burnette’s conviction . Trulieve also stated that Burnette had “no formal involvement” in the founding or operation of the company (aside from his marriage to Rivers). Nonetheless, the optics were concerning: the husband of a top cannabis CEO was literally convicted of bribing officials and boasted of tilting cannabis regulations in his favor. This scandal underscored how big-money interests can corrupt the policymaking process in the cannabis space. It’s a stark example of the lengths to which some individuals linked to cannabis companies will go – including bribery – to secure lucrative advantages, such as market protection or license restrictions.

Conclusion

The wave of THCA hemp bans across the country reveals a convergence of public policy and private interest. On the surface, lawmakers banning delta-8, THCA, and similar products cite health and safety – preventing “unsafe, untested” cannabis analogs from being sold at gas stations or to minors. But the timing and pattern of these bans strongly suggest another motive at play: protecting state-legal cannabis markets from cheap, untaxed competition. In state after state, as soon as a regulated marijuana program takes hold (or is on the horizon), officials move to snuff out the hemp-derived THC trade, often after heavy lobbying from cannabis licensees who don’t want to lose market share. As documented above, many states with legal medical or recreational cannabis – from Colorado, California, and Massachusetts to Mississippi and Alabama – have outlawed THCA products, effectively granting licensed cannabis companies a monopoly on intoxicating THC sales . Even at the federal level, there is momentum to “close the loophole” and ban intoxicating hemp nationally , a policy shift that established cannabis businesses welcome.

At the same time, corruption scandals like the one involving Trulieve’s circle show that the cannabis industry is not immune to old-fashioned graft in the pursuit of profit. The case of Kim Rivers’ husband – a figure at the nexus of business and politics – illustrates how lucrative the cannabis sector can be and the temptations to bribe, bully, or influence officials to craft favorable laws. In Florida’s case, a single, obscure provision (the 30-year rule) helped a few companies dominate an entire market, at the expense of newcomers and minorities – a provision a powerbroker claimed he arranged as a favor to himself. While he ended up in prison, the rule remained on the books for years.

Ultimately, the THCA hemp ban saga and related corruption highlight a central tension in drug reform: as cannabis becomes legal and commercialized, vested interests will fight to shape the rules to their advantage. Big cannabis companies lobby for strict rules on their would-be competitors (whether that’s hemp farmers or smaller license applicants), often under the guise of public safety or “orderly markets.” Sometimes those influence campaigns cross ethical and legal lines, as seen in Florida. For consumers and policymakers, this means it’s crucial to separate genuine public health concerns from rent-seeking behavior. The story of THCA bans isn’t just about obscure chemical loopholes – it’s about money, power, and influence in the rapidly evolving cannabis industry, and the need to remain vigilant against corruption as this industry grows.

Sources: Recent legislative analyses and news reports on state hemp/cannabis laws ; federal bill proceedings ; cannabis industry trade publications and legal experts on the hemp loophole ; and court records/news coverage of the J.T. Burnette bribery case , as summarized above.